Leptin and the Adipocyte Endocrine System

References

• Unger, RH, Zhou, Y-T, Orci, L. Regulation of fatty acid homeostasis in cells, novel role of leptin. Proc Natl Acad Sci USA 1999; 96: 2327–2332.
   PubMed Web of Science ®Google Scholar
• Tataranni, PA. From physiology to neuroendocrinology: a reappraisal of risk factors of body weight gain in humans. Diabetes Metab 1998; 24: 108–115.
   PubMed Web of Science ®Google Scholar
• Ravussin E, Lillioja KS, Knowler WC, et al. Reduced rate of energy expenditure as a risk for body-weight gain. N Engl J Med 1988; 318: 467–472.
   PubMed Web of Science ®Google Scholar
• Schemmel R, Mickelsen O, Gill JL. Dietary obesity in rats: body weight and body fat accretion in seven strains rats. J Nutr 1970; 100: 1041–1048.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Procenca R, Maffie M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature (London) 1994; 372: 425–432.
   PubMed Web of Science ®Google Scholar
• Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978; 14: 141–148.
   PubMed Web of Science ®Google Scholar
• Neel JV. Diabetes mellitus: a “Thrifty Genotype Rendered Detrimental by “Progress”? Am J Hum Genet 1962; 14: 353–362.
   PubMed Web of Science ®Google Scholar
• Astrup A, Raben A, Buemann B, Toubro S. Fat metabolism in the predisposition to obesity. Ann N Y Acad Sci 1997; 827: 417–430.
   PubMed Web of Science ®Google Scholar
• Pagliassotti MJ, Gayles EC, Hill JO. Fat and energy balance. Ann N Y Acad Sci 1997; 827: 431–448.
   PubMed Web of Science ®Google Scholar
• Berk PD, Zhou SL, Kiang CL, et al. Uptake of long chain free fatty acids is selectively up-regulated in adipocytes of Zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus. J Biol Chem 1997; 272: 8830–8835.
   PubMed Web of Science ®Google Scholar
• Berk PD, Zhou S-L, Kiang C-L, et al. Selective up-regulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents. J Biol Chem 1999; 274: 28626–2863.
   PubMed Web of Science ®Google Scholar
• Zhou YT, Shimabukuro M, Wang M-Y, et al. Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells. Proc Natl Acad Sci USA. 1998; 95: 8898–8903.
   PubMed Web of Science ®Google Scholar
• Shimabukuro M, Koyama K, Chen G, et al. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997; 94: 4637–4641.
   PubMed Web of Science ®Google Scholar
• Abumrad N, Harmon C, Ibrahimi A. Membrane transport of long-chain fatty acids: evidence for a facilitated process. J Lipid Res 1998; 39: 2309–2318.
   PubMed Web of Science ®Google Scholar
• Glatz JF, Van Nieuwenhoven FA, Luiken JJ, et al. Role of membrane-associated and cytoplas-mic fatty acid-binding proteins in cellular fatty acid metabolism. Prostaglandins Luekot Essent Fatty Acids 1997; 57: 373–378.
   PubMed Web of Science ®Google Scholar
• Luiken JJ, Arumugam Y, Dyck DJ, et al. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 2001; 276: 40567–40573.
   PubMed Web of Science ®Google Scholar
• Berk PD, Zhou S-L, Kiang C-L, et al. Selective up-regulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents. J Biol Chem 1999; 274: 28626–28631.
   PubMed Web of Science ®Google Scholar
• Memon RA, Fuller J, Moser AH, et al. Regulation of putative fatty acid transporters and acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. Diabetes 1999; 48: 121–127.
   PubMed Web of Science ®Google Scholar
• Havel PJ. Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proc Nutr Soc 2000; 59: 359–371.
   PubMed Web of Science ®Google Scholar
• Iritani N, Sugimoto T, Fukuda H. Gene expressions of leptin, insulin receptors and lipogenic enzymes are coordinately regulated by insulin and dietary fat in rats. J Nutr 2000; 130: 1183–1188.
   PubMed Web of Science ®Google Scholar
• Bai Y, Zhang S, Kim K-S, et al. Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J Biol Chem 1996; 271: 13939–13942.
   PubMed Web of Science ®Google Scholar
• Arvaniti K, Richard D, Picard F, Deshaies Y. Lipid deposition in rats centrally infused with leptin in the presence or absence of corticosterone. Am J Physiol Endocrinol Metab 2001; 282: E809–E816.
   Google Scholar
• Cianflone, K. Acylation stimulating protein and the adipocyte. J Endocrinol 1997; 155: 203–206.
   PubMed Web of Science ®Google Scholar
• Cianflone K, Maslowska M, Sniderman AD. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. Semin Cell Dev Biol 1999; 10: 31–41.
   PubMed Web of Science ®Google Scholar
• Yasruel Z, Cianflone K, Sniderman AD, et al. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 1991; 26: 495–499.
   PubMed Web of Science ®Google Scholar
• Maslowska M, Sniderman AD, Germinario R, Cianflone K. ASP stimulates glucose transport in cultured human adipocytes. Int J Obes Relat Metab Disord 1997; 21: 261–264.
   PubMed Web of Science ®Google Scholar
• Germinario R, Sniderman AD, Manuel S, et al. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein. Metabolism 1993; 42: 574–580.
   PubMed Web of Science ®Google Scholar
• Maslowska M, Scantlebury T, Germinario R, Cianflone K. Acute in vitro production of acylation stimulating protein in differentiated human adipocytes. J Lipid Res 1997; 38: 1–11.
   PubMed Web of Science ®Google Scholar
• Lee Y, Hirose H, Zhou Y-T, Esser V, et al. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes 1997; 46: 408–413.
   PubMed Web of Science ®Google Scholar
• Yeaman SJ. Hormone-sensitive lipase: a multipurpose enzyme in lipid metabolism. Biochim Biophys Acta 1990; 1052: 128–132.
   PubMed Web of Science ®Google Scholar
• Holm C, Osterlund T, Laurell H, Contreras JA. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu Rev Nutr 2000; 20: 365–393.
   PubMed Web of Science ®Google Scholar
• Kraemer FB, Patel S, Saedi, MS, Sztalryd C. Detection of hormone-sensitive lipase in various tissues. I. Expression of an HSL/bacterial fusion protein and generation of anti-HSL antibodies. J Lipid Res 1993; 34: 663–671.
   PubMed Web of Science ®Google Scholar
• Roduit R, Masiello P, Wang SP, Li G, et al. A Role for Hormone-sensitive lipase in glucose-stimulated insulin secretion. Diabetes 2001; 50: 1970–1975.
   PubMed Web of Science ®Google Scholar
• Himms-Hagen J. Brown adipose tissue thermogenesis and obesity. Prog Lipid Res 1989; 28: 67–115.
   PubMed Web of Science ®Google Scholar
• Mulder H, Holst LS, Svensson H, et al. Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in ?-cells. Diabetes 1999; 48: 228–232.
   PubMed Web of Science ®Google Scholar
• Wang SP, Laurin N, Himms-Hagen J, et al. The adipose tissue phenotype of hormone sensitive lipase deficiency in mice. Obesity Res 2001; 9: 119–128.
   PubMedGoogle Scholar
• Osuga J, Ishibashi S, Oka T, et al. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USA 2000; 97: 787–792.
   PubMed Web of Science ®Google Scholar
• Saltiel AR. Another hormone-sensitive triglyceride lipase in fat cells? Proc Natl Acad Sci USA 2000; 97: 535–537.
   PubMed Web of Science ®Google Scholar
• Freubis J, Tsao T-S, Javorschi S, et al. Proteolytic cleavage product of 30 kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98: 2005–2010.
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941–953.
   PubMed Web of Science ®Google Scholar
• Comuzzie AG, Funahashi T, Sonnenberg G, et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 2001; 86: 4321–4325.
   PubMed Web of Science ®Google Scholar
• Wang M-Y, Lee Y, Unger RH. Novel form of lipolysis induced by leptin. J Biol Chem 1999; 274: 17541–17544.
   PubMed Web of Science ®Google Scholar
• Ricquier D, Bouillaud F. The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem J 2000; 345, 161–179.
   PubMed Web of Science ®Google Scholar
• Nedergaard J, Golozoubova V, Matthias A, et al. UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. Biochim Biophys Acta 2001; 1504: 82–106.
   PubMed Web of Science ®Google Scholar
• Weigle DS, Selfridge LE, Schwartz MW, et al. Elevated free fatty acids induce uncoupling protein 3 expression in muscle: a potential explanation for the effect of fasting. Diabetes 1998; 47: 298–302.
   PubMed Web of Science ®Google Scholar
• Brun S, Carmona MC, Mampel T, et al. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes 1999; 48: 1217–1222.
   PubMed Web of Science ®Google Scholar
• Gong DW, Monemdjou S, Gavrilova O, et al. Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J Biol Chem 2000; 275: 16251–16257.
   PubMedGoogle Scholar
• Clapham JC, Arch JR, Chapman H, et al. Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 2000; 406: 415–418.
   PubMedGoogle Scholar
• Gong DW, He Y, Karas M, Reitman M. Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin. J Biol Chem 1997; 272: 24129–24132.
   PubMed Web of Science ®Google Scholar
• Commins SP, Watson PM, Padgett MA, et al. Induction of uncoupling protein expression in brown and white adipose tissue by leptin. Endocrinology 1999; 140: 292–300.
   PubMed Web of Science ®Google Scholar
• Zhou YT, Shimabukuro M, Koyama K, et al. Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci USA 1997; 94: 6386–6390.
   PubMed Web of Science ®Google Scholar
• Combatsiaris TP, Charron MJ. Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment. Diabetes 1999; 48: 128–133.
   PubMed Web of Science ®Google Scholar
• Kamatzu M, Schermerhorn T, Noda M, et al. Augmentation of insulin release by glucose in the absence of extracellular Ca2+: new insights into stimulus-secretion coupling. Diabetes 1997; 46: 1928–1938.
   PubMed Web of Science ®Google Scholar
• Prentki M, Tornheim K, Corkey BE. Signal transduction mechanisms in nutrient-induced insulin secretion. Diabetologia 1997; 40: S32–S41.
   PubMed Web of Science ®Google Scholar
• Trayburn P, Hoggard N, Mercer JG, et al. Leptin: fundamental aspects. Int J Obes Relat Metab Disord 1999; 23: 22–28.
   PubMed Web of Science ®Google Scholar
• Trayburn P, Rayner DV. Hormones and the ob gene product (leptin) in the control of energy balance. Biochem Soc Trans 1996; 24: 565–570.
   PubMed Web of Science ®Google Scholar
• Tsiotra PC, Tsigos C, Raptis SA. TNF-alpha and leptin inhibit basal and glucose-stimulated insulin secretion gene transcription in the HIT-T15 pancreatic cells. Int J Obes Relat Metab Disord 2001; 25: 1018–1026.
   PubMed Web of Science ®Google Scholar
• Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997; 272: 10585–10593.
   PubMed Web of Science ®Google Scholar
• Ferrante AW, Thearle M, Liao T, et al. Effects of leptin deficiency and short-term repletion on hepatic gene expression in genetically obese mice. Diabetes 2001; 50: 2268–2278.
   PubMed Web of Science ®Google Scholar
• Rossetti L, Massillon D, Barzilai N, et al. Short-term effects of leptin on hepatic gluconeogen-esis and in vivo insulin action. J Biol Chem 1997; 272: 27758–27763.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-?; direct role in obesity-linked insulin resistance. Science 1993; 259: 87–91.
   PubMed Web of Science ®Google Scholar
• Hofmann C, Lorenz K, Braithwaite SS, et al. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 1994; 134: 264–270.
   PubMed Web of Science ®Google Scholar
• Hamann AH, Benecke H, Le Marchand-Brustel Y, et al. Characterization of insulin resistance and NIDDM in transgenic misde with reduced brown fat. Diabetes 1995; 44: 1266–1273.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor-? in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409–2415.
   PubMed Web of Science ®Google Scholar
• Kern P, Saghizadeh M, Ong J, et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111–2119.
   PubMed Web of Science ®Google Scholar
• Peraldi P, Xu M, Spiegelman BM. Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling. J Clin Invest 1197; 100: 1863–1869.
   Google Scholar
• Peraldi P, Spiegelman BM. Studies of the mechanism of inhibition of insulin signaling by tumor necrosis factor-?. J Endocrinol 1997; 155: 219–220.
   PubMed Web of Science ®Google Scholar
• Steppan CM, Balley ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001: 409: 307–312.
   Google Scholar
• Kahn CR, Vicent D, Doris A. Genetics of non-insulin-dependent (type II) diabetes mellitus. Annu Rev Med 1996; 47: 509–531.
   PubMed Web of Science ®Google Scholar
• Way JM, Gorgun CZ, Tong Q, et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor agonists. J Biol Chem 2001; 276: 25651–25653.
   PubMed Web of Science ®Google Scholar
• Lehmann JM. An antidiabetic thiazolidinedione is a high-affinity ligand for the nuclear peroxisome proliferator-activated receptor? (PPAR?). J Biol Chem 1995; 270: 12953–12956.
   PubMed Web of Science ®Google Scholar
• Kawamatsu Y, Saraie T, Imamiya E, et al. Studies on antihyperlipidemic agents. I. synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives. Arzneimittelforschung 1980; 30: 454–459.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835–839.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995; 83: 841–850.
   PubMed Web of Science ®Google Scholar
• Forman BM, Tontonoz P, Chen J, et al. 15-deoxy, delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR?. Cell 1995; 83: 803–812.
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Lenhard JM, Willson TM, et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor and promotes adipocyte differentiation. Cell 1995; 83: 813–819.
   PubMed Web of Science ®Google Scholar
• Willson TM, Cobb JE, Cowan DJ, et al. The structure-activity relationship between peroxi-some proliferator-activated receptor ? and the antihyperglycemic activity of thiazolidinediones. J Med Chem 1996; 39: 665–658.
   PubMed Web of Science ®Google Scholar
• Berger J, Bailey P, Biswas C, et al. Thiazolidinediones produce a conformational change peroxisomes proliferator-activated receptor-?: binding and activation correlate with antidia-betic actions in db/db mice. Endocrinology 1996; 137: 4189–4195.
   PubMed Web of Science ®Google Scholar
• Reginato MJ, Lazar MA. Mechanisms by which thiazolidinediones enhance insulin action. Trends Endocrinol Metab 1999; 10: 9–13.
   PubMed Web of Science ®Google Scholar
• Savage DB, Sewter CP, Klenk ES, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-? action in humans. Diabetes 2001; 50: 2199–2202.
   PubMed Web of Science ®Google Scholar
• Moreno-Aliaga MJ, Stanhope KL, Havel PJ. Transcriptional regulation of the leptin promoter by insulin-stimulated glucose metabolism in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2001; 283: 544–548.
   PubMed Web of Science ®Google Scholar
• Havel PJ. Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proc Nutr Soc 2000; 59: 359–371.
   PubMed Web of Science ®Google Scholar
• Ghilardi N, Skoda RC. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor dependent cell line. Mol Endocrinol 1997; 11: 393–399.
   PubMed Web of Science ®Google Scholar
• Diamond FB, Eichler DC, Duckett G, et al. Demonstration of a leptin binding factor in human serum. Biochem Biophys Res Commun 1997; 233: 818–822.
   PubMed Web of Science ®Google Scholar
• Tsigos C, Kyrou I, Chala E, Tsapogas P, et al. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 1999; 48: 1332–1335.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Peraldi P, Budavari A, et al. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in the TNF-alpha- and obesity-induced insulin resistance. Science 1996; 271: 665–668.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Budavari A, Murray D, et al. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 1994; 94: 1543–1549.
   PubMed Web of Science ®Google Scholar
• Sayeed MM. Alteractions in calcium signaling and cellular responses in septic injury. New Horiz 1996; 4: 72–86.
   PubMedGoogle Scholar
• Hotamisligil GS, Johnson RS, Distel RJ, et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996; 274: 1377–1379.
   PubMed Web of Science ®Google Scholar
• Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 1992; 130: 43–52.
   PubMed Web of Science ®Google Scholar
• Van der Poll T, Romijn JA, Endert E, et al. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 1991; 261: E457–E465.
   Google Scholar
• Stephens JM, Lee J, Pilch PF. Tumor necrosis factor-X-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 1997; 272: 971–976.
   PubMed Web of Science ®Google Scholar
• Schreyer SA, Chua SC Jr, LeBoeuf RC. Obesity and diabetes in TNF-alpha receptor-deficient mice. J Clin Invest 1998; 102: 402–411.
   PubMed Web of Science ®Google Scholar
• Sethi J, Hotamisligil BS. The role of TNF? in adipocyte metabolism. Semin Cell Dev Biol 1999; 10: 19–29.
   PubMed Web of Science ®Google Scholar
• Torti FM, Dieckmann B, Beutler B, et al. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science 1985; 229: 867–869.
   PubMed Web of Science ®Google Scholar
• Zhang B, Berger J, Hu E, et al. Negative regulation of peroxisome proliferator-activated receptor-gamma expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol Endocrinol 1996; 10: 1457–1466.
   PubMedGoogle Scholar
• Berg M, Fraker DL, Alexander HR. Characterization of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes. Cytokine 1994; 6: 425–432.
   PubMed Web of Science ®Google Scholar
• Greenberg AS, Nordon RP, McIntosh J, et al. Interleukin-6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin-6 in cancer cachexia. Cancer Res 1992; 52: 4113–4116.
   PubMed Web of Science ®Google Scholar
• Okuno A, Tamemoto H, Tobe K, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998; 101: 1354–1361.
   PubMed Web of Science ®Google Scholar
• Matthys P, Billiau A. Cytokines and cachexia. Nutrition 1997; 13: 763–770.
   PubMed Web of Science ®Google Scholar
• Funahashi T, Nakamura T, Shimomura I, et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999; 38: 202–206.
   PubMed Web of Science ®Google Scholar
• Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998; 22: 1145–1158.
   PubMed Web of Science ®Google Scholar
• Sawdey MS, Loskutoff DJ. Regulation of Murine Type-1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-?, and transforming growth factor ?. J Clin Invest 1991; 88: 1346–53.
   PubMed Web of Science ®Google Scholar
• Samad F, Yamamoto K, Loskutoff DJ. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor- and li-popolysaccharide. J. Clin Invest 1996; 97: 37–46.
   PubMed Web of Science ®Google Scholar
• Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 2000; 148: 209–214.
   PubMed Web of Science ®Google Scholar
• Mohamed-Ali V, Goodrick S. Rawesh A, et al. Human subcutaneous adipose tissue secretes interleukin-6 but not TNF-? in vivo. J Clin Endocrinol Metab 1997; 82: 4196–4200.
   Google Scholar
• Fried SK, Bunkin D, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83: 847–850.
   PubMed Web of Science ®Google Scholar
• Jones RH, Kennedy RL. Cytokines and hypothalamic-pituitary function. Cytokine 1993; 5: 531–538.
   PubMed Web of Science ®Google Scholar
• Yudkin JS, Stehouwer CD, Emeis JJ, et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial function: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972–978.
   PubMed Web of Science ®Google Scholar
• Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metallo-proteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493–2503.
   PubMed Web of Science ®Google Scholar
• van der Poll T, Levi M, Hack CE, et al. Elimination of interleukin-6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994; 179: 1253–1259.
   PubMed Web of Science ®Google Scholar
• Kanemaki T, Kitade H, Kaibori M, et al. Interleukin 1 beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 1998; 27: 1296–1303.
   PubMed Web of Science ®Google Scholar
• Robinson LJ, Busconi L, Michel T. Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J Biol Chem 1995; 270: 995–998.
   PubMed Web of Science ®Google Scholar
• Steinberg HO, Tarshoby M, Monestel R, et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997; 100: 1230–1239.
   PubMed Web of Science ®Google Scholar
• Navarra P, Tsagarakis S, Faria MS, et al. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 1991; 128: 37–44.
   PubMed Web of Science ®Google Scholar
• Shimon I, Yan X, Ray DW, et al. Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adreno-corticotropin hormone and growth hormone secretion. J Clin Invest 1997; 100: 357–363.
   PubMed Web of Science ®Google Scholar
• Tsigos C, Papanicolaou DA, Defensor R, et al. Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroimmunology 1997; 66: 54–62.
   Google Scholar
• Rivier C, Vale W. Cytokines act within the brain to inhibit lutenizing hormone secretion and ovulation in the rat. Endocrinology 1990; 127: 849–856.
   PubMed Web of Science ®Google Scholar
• Ozawa M, Sata K, Han DC, et al. Effects of tumor necrosis factor-X/cachectin on thyroid hormone metabolism in mice. Endocrinology 1988; 123: 1461–1467.
   PubMed Web of Science ®Google Scholar
• Sato K, Satoh T. Shizume K, et al. Inhibition of I125 organification and thyroid hormone release by inerleukin-1, tumor necrosis factor-1, tumor necrosis factor-X and interferon-? in human thyrocytes in suspension cultures. J Clin Endocrinol Metab 1990; 70: 1735–1743.
   PubMed Web of Science ®Google Scholar
• Kageyama K, Watanobe H, Takebe K. In vivo evidence that arginine vasopressin is involved in the adrenocorticotropin response induced by interleukin-6 but not by tumor necrosis factor-alpha in the rat. Neuroimmunomodulation 1995; 2: 137–140.
   PubMed Web of Science ®Google Scholar
• Tsigos C, Papanicolaou Da, Defensor R, et al. Dos effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroimmunology 1997; 66: 54–62.
   Google Scholar
• Kennedy JA, Wellby ML, Zotti R. Effect of interleukin-1 beta, tumor necrosis factor-alpha and interleukin-6 on the control of thyrotropin secretion. Life Sci 1995; 57: 487–501.
   PubMed Web of Science ®Google Scholar
• Pinkney JH, Goodrick SJ, Katz J, et al. Leptin and the pituitary-thyroid axis: A comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clin Endocrinol 1998; 49: 583–588.
   PubMed Web of Science ®Google Scholar
• Pinkney JH, Coppack SW, Mohamed-Ali V. Effect of isoprenaline on plasma leptin and lipolysis in humans. Clin Endocrinol 1998; 48: 407–411.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Escobar del Rey F, Morreale de Escobar G. Thyroid hormones influence serum leptin concentrations in the rat. Endocrinology 1997; 138: 4485–4488.
   PubMed Web of Science ®Google Scholar
• Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000; 62: 413–437.
   PubMed Web of Science ®Google Scholar
• Trayhurn P, Duncan JS, Rayner DV, et al. Rapid inhibition of ob gene expression and circulating leptin levels in lean mice the beta 3-adrenoceptor agonists BRL 35135A and ZD2079. Biochem Biophys Res Commun 1996; 228: 605–610.
   PubMed Web of Science ®Google Scholar
• Donahoo WT, Jensen DR, Yost TJ, et al. Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion. J Clin Endocrinol Metab 1997; 82: 4139–4143.
   PubMed Web of Science ®Google Scholar
• Pinkney JH, Coppack SW, Mohamed-Ali V. Effect of isoprenaline on plasm leptin and lipolysis in humans. Clin Endocrinol 1998; 48: 407–411.
   PubMed Web of Science ®Google Scholar
• Mazuaki H, Ogawa Y, Isse N, et al. Human obese gene expression. Diabetes 1995; 44: 855–858.
   PubMed Web of Science ®Google Scholar
• Kallen CB, Lazar M. Antidiabetic thiazoladinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA l996; 93: 5793–5796.
   Google Scholar
• Mantzoros CS, Qu D, Frederich RC, et al. Activation of beta3 adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes 1996; 45: 909–914.
   PubMed Web of Science ®Google Scholar
• Carpenter LR, Farruggella TJ, Symes A, et al. Enhancing leptin response by presenting SH-2 containing phosphatase 2 interaction with Ob receptor. Proc Natl Acad Sci USA 1998; 95: 6061–6066.
   PubMed Web of Science ®Google Scholar
• Chung CD, Liao J, Liu V, et al. Specific inhibition of STAT3 signal transduction by PIAS3. Science 1997; 278: 1803–1805.
   PubMed Web of Science ®Google Scholar
• Bjorbaek C, Elmquist JK, Frantz JD, et al. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell l998; l: 619–625.
   Google Scholar
• Wang Z, Zhou Y-T, Kakuma T, et al. Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling. Biochem Biophysic Res Commun 2000; 277: 20–26.
   PubMed Web of Science ®Google Scholar
• Grunfeld C, Zhao C, Fuller J, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996; 97: 2152–2157.
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–809.
   PubMed Web of Science ®Google Scholar
• Sierra-Honigmann MR, Nath AK, Murakami C, et al. Biological action of leptin as an angiogenic factor. Science 1998; 281: 1683–1686.
   PubMed Web of Science ®Google Scholar
• Lord GM, Matarese G, Howard JK, et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897–901.
   PubMed Web of Science ®Google Scholar
• Lin Y, Rajala MW, Berger JP, et al. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem 2001; 276: 42077–42083.
   PubMed Web of Science ®Google Scholar
• Napolitano A, Lowell BB, Damm D, et al. Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass. Int J Obes Relat Metab Disord 1994; 18: 213–218.
   PubMed Web of Science ®Google Scholar
• Flier JS, Lowell B, Napolitano A, et al. Adipsin: regulation and dysregulation in obesity and other metabolic states. Recent Prog Horm Res 1989; 45: 567–580.
   PubMedGoogle Scholar
• Flier JS, Cook KS, Usher P, et al. Severely impaired adipsin expression in genetic and acquired obesity. Science 1987; 237: 405–408.
   PubMed Web of Science ®Google Scholar
• Baldo A, Sniderman AD, St Luce S, et al. Signal transduction pathway of acylation stimulating protein: involvement of protein kinase C. J Lipid Res 1995; 36: 1415–1426.
   PubMed Web of Science ®Google Scholar
• Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995 270: 26746–26749.
   PubMed Web of Science ®Google Scholar
• Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697–10703.
   PubMed Web of Science ®Google Scholar
• Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473–2476.
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Waki H, Kamon J, et al. Inhibition of RXR and PPAR gamma ameliorates diet-induced obesity and type diabetes. J Clin Invest 2001; 108: 1001–1013.
   PubMed Web of Science ®Google Scholar
• Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000; 96: 1723–1732.
   PubMed Web of Science ®Google Scholar
• Kihara ON, Arita Y, Okamoto Y, et al. Adiponectin, an adipocyte-derived plasma protein inhibits endothelial NF-?B signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296–1301.
   PubMed Web of Science ®Google Scholar
• Okamoto Y, Arita Y, Nishida M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000; 32: 47–50.
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 1999; 892: 146–154.
   PubMed Web of Science ®Google Scholar
• Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–1599.
   PubMed Web of Science ®Google Scholar
• Hamsten A, Wiman B, de Faire U, et al. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557–1563.
   PubMed Web of Science ®Google Scholar
• Auwerx J, Bouillon R, Collen D, et al. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 1988; 8: 68–72.
   PubMedGoogle Scholar
• Vague P, Juhan-Vague I, Aillaud MF, et al. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 1986; 35: 250–253.
   PubMed Web of Science ®Google Scholar
• Shimomura I, Funahashi T, Takahashi M, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Med 1996; 2: 800–803.
   PubMed Web of Science ®Google Scholar
• Alessi MC, Peiretti F, Morange P, et al. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46: 860–867.
   PubMed Web of Science ®Google Scholar
• Sundell IB, Dahlgren S, Ranby M, et al. Reduction of elevated plasminogen activator inhibitor levels during modest weight loss. Fibrinolysis 1989; 3: 51–53.
   Google Scholar
• Velthuis-te Wierik EJ, Meijer P, Kluft C, et al. Beneficial effect of a moderately energy-restricted diet on fibrinolytic factors in non-obese men. Metabolism 1995; 44: 1548–1552.
   PubMed Web of Science ®Google Scholar
• Eriksson P, Reynisdottir S, Lonnqvist F, et al. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia 1998; 41: 65–71.
   PubMed Web of Science ®Google Scholar
• Potter Van Loon BJ, de Bart ACW, Radder JK, et al. Acute exogenous hyperinsulinemia does not result in elevation of plasma plasminogen activator inhibitor 1 concentration in humans. Fibrinolysis 1990; 4: 93–94.
   Google Scholar
• Alessi MC, Peiretti P, Morange P, et al. Production of plasminogen activator inhibitor 1 by human adipose tissue. Diabetes l997; 46: 860–867.
   Google Scholar
• Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000; 11: 327–332.
   PubMed Web of Science ®Google Scholar
• Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987; 45: 277–282.
   PubMed Web of Science ®Google Scholar
• Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1996; 20: 291–302.
   PubMed Web of Science ®Google Scholar
• Katz JR, Mohamed-Ali V, Wood PJ, et al. An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue. Clin Endocrinol 1999; 50: 63–68.
   PubMed Web of Science ®Google Scholar
• Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect “Cushing’s disease of the omentum”? Lancet 1997; 349: 1210–1213.
   PubMed Web of Science ®Google Scholar
• Tchernof A, Despres JP, Belanger A, et al. Reduced testosterone and adrenal C19 steroid levels in obese men. Metabolism 1995; 44: 513–519.
   PubMed Web of Science ®Google Scholar
• Yang K. Khalil MW, Strutt BJ, et al. 11 ?-hydroxy-steroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: effect on aromatase activity. J Steroid Biochem Mol Biol 1997; 60: 247–253.
   PubMed Web of Science ®Google Scholar
• Faloia E, Camilloni MA, Giacchetti G, et al. Adipose tissue as an endocrine organ? A review of some recent data. Eat Weight Disord 2000; 5: 116–123.
   PubMedGoogle Scholar
• Arvanti K, Ricquier D, Champigny O, et al. Leptin and corticosterone have opposite effects on food intake and the expression of UCP1 mRNA in brown adipose tissue of ob/ob mice. Endocrinology 1998; 139: 4000–4003.
   PubMed Web of Science ®Google Scholar
• Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250–252.
   PubMed Web of Science ®Google Scholar
• Cosat A, Poma A, Martignoni E, et al. Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, form hypothalamic explants. Neuroreport l997; 8: 1131–1134.
   Google Scholar
• Nam SY, Marcus C. Growth hormone and adipocyte function in obesity. Hormone Research 2000; 53 Suppl l: 87–97.
   Google Scholar
• Boney CM, Gruppuso PA, Faris RA, et al. The critical role of shc in insulin-like growth factor-l mediated mitogenesis and differentiation in 3T3-L1 preadipocytes. Mol Endocrinol 2000; 14: 805–813.
   PubMed Web of Science ®Google Scholar
• Modan-Moses D, Janicot M, McLenithan JC, et al. Expression and function of insulin/insulinlike growth factor I hybrid receptors during differentiation of 3T3-L1 preadipocytes. Biochem J l998; 333: 825–831.
   Google Scholar
• Richardson RL, Hausman GJ, Wright JT. Growth factor regulation of insulin-like growth (IGF) binding proteins (IGFBP) and preadipocyte differentiation in porcine stromal-vascular cell cultures. Growth Devel Aging 1998; 62: 3–12.
   PubMedGoogle Scholar
• Bornstein SR, Uhlmann K, Haidan A, et al. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland. Diabetes l997; 46: 1235–1238.
   Google Scholar
• Karlsson C, Lindell K, Ottosson M, et al. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 1998; 83: 3925–3929.
   PubMed Web of Science ®Google Scholar
• Engeli S. Gorzelniak K, Kreutz R, et al. Coexpression of renin-angiotensin system genes in human adipose tissue. J. Hypertens. 1999; 17: 555–560.
   PubMed Web of Science ®Google Scholar
• Frederich RC Jr, Kahn BB, Peach MJ, et al. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992; 19: 339–344.
   PubMed Web of Science ®Google Scholar
• Jones BH, Sandridge MK, Taylor JW, et al. Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am J Physiol 1997; 42: R236–R242.
   Google Scholar
• Darimont C, Standridge MK, Moustaid N. Angiotensin 2 increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1994; 138: 1512–1519.
   Google Scholar
• Benabe JE, Martinez-Maldonato M. Nutritional influences on renin-angiotensin gene expression. Nutr Metab Cardiovasc Dis 1996; 6: 46–52.
   Web of Science ®Google Scholar
• Aubert J, Darimont C, Safonova I, et al. Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells. Biochem J 1997; 328: 701–706.
   PubMed Web of Science ®Google Scholar
• Malendowica LK, Nussdorfer GG, Markowska A. Effects of recombinant murine leptin on steroid secretion of dispersed rat adrenocortical cells. J Steroid Biochem Mol Biol l997; (1-3): 123–125.
   Google Scholar
• Haynes WG. Interaction between leptin and sympathetic nervous system in hypertension. Curr Hypertens Rep 2000; 3: 311–318.
   Google Scholar
• Henriksen JH, Moller S, Andersen UB, et al. Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin. Clin Sci (Colch) 2000; 99: 527–534.
   Google Scholar
• Adamczak M, Kokot F, Wiecek AW. Relationship between plasma renin profile and leptinaemia in patients with essential hypertension. J Hum Hypertens 2000; 14: 503–509.
   PubMed Web of Science ®Google Scholar